Evidence map›Paper›PMID 35006392›Full record

ArticleEJNMMI radiopharmacy and chemistry2022

Correction to: Closing the gap between

Javier Ajenjo, Gianluca Destro, Bart Cornelissen, Véronique Gouverneur

Abstract readPublished Erratum
In one paragraph

Article in EJNMMI radiopharmacy and chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Javier Ajenjo *Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, OX3 7DQ, UK.
Gianluca Destro *Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, OX3 7DQ, UK.
Bart CornelissenMedical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, OX3 7DQ, UK.
Véronique GouverneurChemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, OX1 3TA, UK. veronique.gouverneur@chem.ox.ac.uk.ORCID http://orcid.org/0000-0001-8638-5308

Funding

Cancer Research UK 23970Medical Research Council MR/S008209/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35006392
PMCPMC8748566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.